0.6397
6.65%
+0.0399
P3 Health Partners Inc Stock (PIII) Forecast
The P3 Health Partners Inc (PIII) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.9197, representing a +43.77% increase from the current price of $0.6397. The highest analyst price target is $1.6533, and the lowest is $0.1861.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PIII Price Target
Average 1.9896
(+211.01% Upside)
Is P3 Health Partners Inc (PIII) A Buy Now?
Oscillators
Name | Value | Action |
---|---|---|
RSI(14) | 50.15 | Neutral |
STOCH(9,6) | 54.04 | Neutral |
STOCHRSI(14) | 100.00 | Sell |
MACD(12,26) | -0.0715 | Buy |
ADX(14) | 25.22 | Buy |
William %R | -12.14 | Sell |
CCI(14) | 174.53 | Buy |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
Period | Simple | Exponential |
---|---|---|
MA10 |
0.5285
Buy
|
0.5583
Buy
|
MA20 |
0.5523
Buy
|
0.5965
Buy
|
MA50 |
0.8116
Sell
|
0.7627
Sell
|
MA100 |
1.0014
Sell
|
0.971
Sell
|
MA200 |
1.3406
Sell
|
1.2426
Sell
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, PIII could be considered a Moderate Sell, with 17 technical analysis indicators signaling 7 Buy signals, 8 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on PIII, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 50.15 indicates that PIII is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 54.04 indicates that PIII is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that PIII is oversold. This suggests that PIII price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 25.22 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 174.53 indicates that PIII is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term PIII price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about P3 Health Partners Inc financial reports and earnings history, P3 Health Partners Inc (PIII) stock could reach $7.4682 by 2030, $5.1112 by 2040 and $18.57 by 2050. See the projected annual prices until 2050 of the P3 Health Partners Inc stock below:
- P3 Health Partners Inc (PIII) is expected to reach an average price of $19.38 in 2035, with a high prediction of $19.27 and a low estimate of $19.74. This indicates an $2,929% rise from the last recorded price of $0.6397.
- P3 Health Partners Inc (PIII) stock is projected to chart a bullish course in 2040, with an average price target of $4.7718, representing an $645.95% surge from its current level. The forecast ranges from a conservative $4.7918 to a sky-high $5.1112.
- Our analysts predict P3 Health Partners Inc (PIII) to jump 1,556% by 2045, soaring from $10.74 to an average price of $10.60, potentially reaching $11.25. While $10.74 is the low estimate, the potential upside is significant.
- P3 Health Partners Inc (PIII) stock is expected to climb by 2050, reaching an average of $18.46, a $2,786% jump from its current level. However, a wide range of estimates exists, with high and low targets of $18.57 and $18.62, respectively, highlighting the market's uncertainty.
P3 Health Partners Inc Stock (PIII) Year by Year Forecast
P3 Health Partners Inc Stock (PIII) Price Forecast for 2024
Our forecast for PIII stock price in 2024 now indicates an average price target of $1.9792 with a high forecast of $3.9486 and a low forecast of $0.00981. The average prediction reflects an increase of +209.40% from the last recorded price of $0.6397.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
June, 2024 | $0.9433 | $0.1861 | $1.6533 | +47.46% |
July, 2024 | $3.0142 | $0.7655 | $3.8107 | +371.20% |
August, 2024 | $2.953 | $2.4864 | $3.9486 | +361.62% |
September, 2024 | $0.6817 | $0.5717 | $3.7052 | +6.57% |
October, 2024 | $0.2573 | $0.0305 | $1.1639 | -59.77% |
November, 2024 | $0.2786 | $0.193 | $0.577 | -56.45% |
December, 2024 | $0.9802 | $0.238 | $1.2102 | +53.22% |
P3 Health Partners Inc Stock (PIII) Price Forecast for 2025
P3 Health Partners Inc Stock (PIII) is expected to reach an average price of $1.6903 in 2025, with a high prediction of $3.3777 and a low estimate of $0.00295. This indicates an +164.23% rise from the last recorded price of $0.6397.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2025 | $1.1511 | $0.5224 | $2.0767 | +79.94% |
February, 2025 | $1.5698 | $0.9263 | $3.3777 | +145.40% |
March, 2025 | $1.3486 | $0.7142 | $2.5078 | +110.82% |
April, 2025 | $1.0095 | $0.8395 | $2.2208 | +57.81% |
May, 2025 | $0.5883 | $0.2183 | $2.5496 | -8.04% |
June, 2025 | $1.433 | $0.2895 | $1.0552 | +124.01% |
July, 2025 | $1.652 | $1.6308 | $1.6442 | +158.25% |
August, 2025 | $1.6033 | $1.7019 | $1.7678 | +150.63% |
September, 2025 | $1.8136 | $1.731 | $1.7847 | +183.51% |
October, 2025 | $1.2436 | $1.4136 | $1.4724 | +94.40% |
November, 2025 | $1.0851 | $0.00295 | $2.03 | +69.63% |
December, 2025 | $1.1361 | $0.9761 | $3.2717 | +77.59% |
P3 Health Partners Inc Stock (PIII) Price Forecast for 2026
The predicted value for P3 Health Partners Inc (PIII) in 2026 is set at an average of $0.6946. Estimates vary from a peak of $1.3883 to a trough of $0.000892, indicating an +8.58% surge from the present price of $0.6397.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2026 | $0.2748 | $0.2348 | $1.3883 | -57.04% |
February, 2026 | $0.0136 | $0.0164 | $0.8136 | -97.88% |
March, 2026 | $0.2823 | $0.0823 | $0.4423 | -55.87% |
April, 2026 | $0.1933 | $0.1345 | $1.1657 | -69.79% |
May, 2026 | $0.118 | $0.1446 | $0.2454 | -81.55% |
June, 2026 | $0.2493 | $0.1258 | $0.0993 | -61.04% |
July, 2026 | $0.0683 | $0.2227 | $0.1549 | -89.32% |
August, 2026 | $0.0804 | $0.00605 | $0.5539 | -87.43% |
September, 2026 | $0.0714 | $0.0399 | $0.318 | -88.84% |
October, 2026 | $0.2601 | $0.0835 | $0.3601 | -59.34% |
November, 2026 | $0.0959 | $0.0394 | $0.3767 | -85.02% |
December, 2026 | $0.081 | $0.000892 | $0.161 | -87.34% |
P3 Health Partners Inc Stock (PIII) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for P3 Health Partners Inc (PIII) is $2.9065, with a high forecast of $4.4853 and a low forecast of $1.3278. This indicates an +354.36% increase from the last price of $0.6397.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2027 | $4.4609 | $4.9696 | $4.4853 | +597.34% |
February, 2027 | $3.8234 | $4.2334 | $4.0365 | +497.68% |
March, 2027 | $1.5915 | $2.2603 | $3.419 | +148.79% |
April, 2027 | $1.524 | $1.3278 | $0.964 | +138.24% |
May, 2027 | $3.6665 | $2.4296 | $2.2209 | +473.16% |
June, 2027 | $4.4447 | $3.7034 | $3.409 | +594.80% |
July, 2027 | $4.3372 | $4.3159 | $4.3072 | +578.00% |
August, 2027 | $2.9497 | $3.3897 | $3.9228 | +361.10% |
September, 2027 | $2.6178 | $2.3465 | $2.2153 | +309.22% |
October, 2027 | $2.0703 | $2.0247 | $2.3184 | +223.64% |
November, 2027 | $2.1628 | $2.4328 | $1.9016 | +238.10% |
December, 2027 | $2.3409 | $2.1297 | $1.8141 | +265.94% |
P3 Health Partners Inc Stock (PIII) Price Forecast for 2028
In 2028, P3 Health Partners Inc (PIII) is projected to reach an average price of $2.5105, with a high projection of $4.6354 and a low estimate of $0.3856. This indicates an +292.45% rise from the last price of $0.6397.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2028 | $2.6334 | $2.0278 | $1.6184 | +311.67% |
February, 2028 | $4.5259 | $3.4791 | $4.1803 | +607.51% |
March, 2028 | $4.5841 | $4.6241 | $4.6085 | +616.60% |
April, 2028 | $4.4066 | $4.5052 | $4.6354 | +588.85% |
May, 2028 | $4.2247 | $4.4101 | $4.4593 | +560.42% |
June, 2028 | $3.7572 | $3.9272 | $4.0803 | +487.34% |
July, 2028 | $1.2997 | $1.4997 | $2.0785 | +103.18% |
August, 2028 | $1.0879 | $0.3856 | $0.9834 | +70.06% |
September, 2028 | $1.8204 | $1.4635 | $1.5405 | +184.56% |
October, 2028 | $1.9529 | $1.9616 | $1.8116 | +205.28% |
November, 2028 | $1.501 | $1.671 | $2.1249 | +134.64% |
December, 2028 | $1.4835 | $1.5266 | $1.8679 | +131.91% |
P3 Health Partners Inc Stock (PIII) Price Forecast for 2029
The 2029 price forecast for P3 Health Partners Inc Stock (PIII) is $4.9811 on average, with a high prediction of $9.4129 and a low estimate of $0.5493. This represents an +678.66% increase from the previous price of $0.6397.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2029 | $1.5016 | $1.6416 | $1.6161 | +134.74% |
February, 2029 | $1.5741 | $1.6241 | $1.5329 | +146.07% |
March, 2029 | $1.3266 | $1.4966 | $1.5098 | +107.38% |
April, 2029 | $1.0491 | $1.1235 | $1.0079 | +64.01% |
May, 2029 | $0.8973 | $0.9173 | $0.9549 | +40.26% |
June, 2029 | $0.5798 | $0.6498 | $0.8029 | -9.37% |
July, 2029 | $0.6153 | $0.5667 | $0.4852 | -3.82% |
August, 2029 | $0.6081 | $0.5493 | $0.6669 | -4.94% |
September, 2029 | $9.3563 | $9.9294 | $9.4129 | +1,363% |
October, 2029 | $8.6035 | $8.7035 | $8.8998 | +1,245% |
November, 2029 | $6.1973 | $6.8661 | $7.377 | +868.78% |
December, 2029 | $6.001 | $5.8692 | $5.441 | +838.10% |
P3 Health Partners Inc Stock (PIII) Price Forecast for 2030
P3 Health Partners Inc Stock (PIII) is expected to reach an average price of $6.8237 in 2030, with a high forecast of $8.3657 and a low forecast of $5.2817. This signifies an +966.71% surge from the last price of $0.6397.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2030 | $8.1482 | $6.8745 | $7.4682 | +1,174% |
February, 2030 | $8.632 | $7.9551 | $7.6285 | +1,249% |
March, 2030 | $8.3957 | $8.4389 | $8.3657 | +1,212% |
April, 2030 | $6.8795 | $7.3195 | $7.9492 | +975.43% |
May, 2030 | $6.3867 | $6.1798 | $6.1129 | +898.39% |
June, 2030 | $5.7105 | $5.697 | $6.0551 | +792.68% |
July, 2030 | $5.3776 | $5.9442 | $5.4773 | +740.65% |
August, 2030 | $5.6914 | $5.5445 | $5.2611 | +789.70% |
September, 2030 | $5.8552 | $5.2817 | $4.8402 | +815.30% |
October, 2030 | $7.4824 | $6.6686 | $7.3487 | +1,070% |
November, 2030 | $7.5161 | $7.5561 | $7.5727 | +1,075% |
December, 2030 | $7.2099 | $7.3085 | $7.5031 | +1,027% |
Cap:
|
Volume (24h):